WDNAWisdomTree BioRevolution Fund
4.21%
Distribution yield
As of 6/15/2026
0.11%
30-day SEC yield
As of 6/15/2026
0.45%
Net expense ratio
As of 6/16/2026
6/3/2021
Inception Date
Overview
Product Description
The WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index. Learn more about the Index that WDNA is designed to track.
Why WDNA?
- Gain targeted exposure to companies that seek to benefit from the revolution in biology focused technologies
- Use to complement core portfolios with innovative growth megatrends in the biology space
- Satisfies demand for multi-sector genetics and biotechnology investments with strong growth characteristics
Fund Overview
| Product Overview | As of 6/16/2026 |
|---|---|
| Expense Ratio | 0.45% |
| CUSIP | 97717Y618 |
| Total Assets (000) | $2,376.77 |
| Shares Outstanding | 130,000 |
| Distribution Yield | 4.21% |
| SEC 30-day Yield | 0.11% |
| Options Available* | No |
| Inception Date | 6/3/2021 |
| Fiscal Year End | 06/30 |
*Options are not suitable for all investors.
| Trading Information | As of 6/15/2026 |
|---|---|
| 30-Day Average Volume | 941 |
| Implied Liquidity™ (Shares) | 500,341,571 |
| Implied Liquidity (000) | $9,156,382.34 |
| Lead Market Maker | Flow Traders |
| Related index Symbol | WTDNAN |
| NAV Symbol | WDNA.NV |
| Shares Out. Symbol | WDNA.SO |
Net Asset Value
| Net Asset Value | As of 6/16/2026 |
|---|---|
| NAV | $18.283 |
| Change | -$0.018 |
| Change % | -0.10% |
| Premium/Discount to NAV | 0.064% |
Closing Market Price
| Closing Market Value | As of 6/15/2026 |
|---|---|
| Closing Market Price | $18.312 |
| Change | $0.303 |
| Change % | 1.68% |
| Median Bid/Ask Spread (30-Day Avg.) | 0.67% |
Market Capitalization
| Market Capitalization | As of 6/15/2026 |
|---|---|
| Total Market Capitalization ($ Trillion) | 4.21 |
| Fund MarketCap Breakdown | |
| Large Cap (> $10 Billion) | 50.42% |
| Mid Cap (≥ $2 Billion and ≤ $10 Billion) | 33.47% |
| Small Cap (< $2 Billion) | 16.11% |
Portfolio Characteristics
| Portfolio Characteristics | As of 6/15/2026 |
|---|---|
| Dividend Yield | 0.62% |
| Price/Earnings | -22.74 |
| Estimated Price/Earnings | -38.34 |
| Price/Book | 3.35 |
| Price/Sales | 3.59 |
| Price/Cash Flow | -39.09 |
| Gross Buyback Yield | 0.91% |
| Net Buyback Yield | -2.97% |
The measures above refer to the underlying securities of the holdings in the Funds' portfolios and should not be considered reflective of the Funds' performance.
Growth of Hypothetical 10K
Results are not indicative of future performance.
Total Returns
Month End Performance (5/31/2026)
| Cumulative | 1 Month | 3 Month | YTD | Since Inception* | |
|---|---|---|---|---|---|
| Underlying Index Returns | 3.23% | 0.02% | 8.62% | -21.67% | |
| NAV Returns | 3.26% | -0.05% | 8.52% | -21.86% | |
| Market Price Returns | 3.09% | 0.27% | 8.65% | -21.84% | |
| Average Annual | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception* |
| Underlying Index Returns | 57.01% | 4.63% | N/A | N/A | -4.77% |
| NAV Returns | 56.50% | 4.62% | N/A | N/A | -4.82% |
| Market Price Returns | 55.51% | 4.63% | N/A | N/A | -4.81% |
Quarter End Performance (3/31/2026)
| Cumulative | Since Inception* | ||||
|---|---|---|---|---|---|
| Underlying Index Returns | -25.71% | ||||
| NAV Returns | -25.86% | ||||
| Market Price Returns | -25.93% | ||||
| Average Annual | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception* |
| Underlying Index Returns | 42.35% | 2.47% | N/A | N/A | -5.97% |
| NAV Returns | 41.99% | 2.48% | N/A | N/A | -6.01% |
| Market Price Returns | 41.41% | 2.41% | N/A | N/A | -6.03% |
*Fund inception Date 6/3/2021
Performance is historical and does not guarantee future results. Current performance may be lower or higher than quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above.
WisdomTree shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Total Returns are calculated using the daily 4:00pm net asset value (NAV). Market price returns reflect the midpoint of the bid/ask spread as of the close of trading on the exchange where Fund shares are listed. Market price returns do not represent the returns you would receive if you traded shares at other times.
After Tax Returns
Month End Performance 5/31/2026
| Cumulative | 1 Month | 3 Month | Since Inception* | ||
|---|---|---|---|---|---|
| After Tax Held | 3.26% | -0.05% | -23.51% | ||
| After Tax Sold | 1.93% | -0.03% | -17.21% | ||
| Average Annual | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception* |
| After Tax Held | 53.93% | 3.92% | N/A | N/A | -5.22% |
| After Tax Sold | 33.51% | 3.29% | N/A | N/A | -3.71% |
Quarter End Performance 3/31/2026
| Cumulative | Since Inception* | ||||
|---|---|---|---|---|---|
| After Tax Held | -27.43% | ||||
| After Tax Sold | -20.20% | ||||
| Average Annual | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception* |
| After Tax Held | 39.66% | 1.79% | N/A | N/A | -6.42% |
| After Tax Sold | 24.99% | 1.67% | N/A | N/A | -4.57% |
*Fund inception Date 6/3/2021
Performance is historical and does not guarantee future results. Current performance may be lower or higher than quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above.
WisdomTree shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Total Returns are calculated using the daily 4:00pm net asset value (NAV). Market price returns reflect the midpoint of the bid/ask spread as of the close of trading on the exchange where Fund shares are listed. Market price returns do not represent the returns you would receive if you traded shares at other times.
After-Tax Held Returns represent return on Fund shares after taxes on distributions and assumes Fund shares have not been sold. After-Tax Sold Returns represent returns on Fund shares after taxes on distributions and the sale of the Fund shares.
After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor's individual tax rates and may differ from those shown.
In some cases the return after taxes may exceed the return before taxes due to an assumed tax benefit from any losses on a sale of fund shares at the end of the measurement period.
Country Allocation
| Country | Weight (%) |
|---|---|
| United States | 85.54% |
| Switzerland | 3.37% |
| Germany | 3.05% |
| Netherlands | 2.11% |
| Unknown | 1.93% |
| Denmark | 1.87% |
| United Kingdom | 0.83% |
| Belgium | 0.71% |
| Australia | 0.59% |
Holdings
As of 6/16/2026
| Name | Weight (%) |
|---|---|
| Twist Bioscience Corp | 5.53 |
| Eli Lilly & Co | 4.3 |
| Moderna Inc | 3.69 |
| Johnson & Johnson | 3.1 |
| United Therapeutics Corp | 2.79 |
| Tempus Ai Inc | 2.24 |
| Darling Ingredients Inc | 2.2 |
| Immunome Inc | 2.15 |
| Beam Therapeutics Inc | 2.12 |
| Natera Inc | 2.12 |
| Remaining Portfolio | 69.75 |
*Holdings are subject to change without notice.
Sector Breakdown
As of 6/15/2026
| Name | Weight (%) |
|---|---|
Health Care | 88.67 |
Materials | 5.41 |
Consumer Staples | 4.53 |
Energy | 1.39 |
*Sectors are subject to change without notice
Recent Distributions
| Ex-Dividend Date | Record Date | Payable Date | Ordinary Income | Short Term Capital Gains | Long Term Capital Gains | Return of Capital | Total Distribution |
|---|---|---|---|---|---|---|---|
| 12/26/2025 | 12/26/2025 | 12/30/2025 | $0.77052 | $0.00000 | $0.00000 | $0.00000 | $0.77052 |
| 12/26/2024 | 12/26/2024 | 12/30/2024 | $0.10710 | $0.00000 | $0.00000 | $0.00000 | $0.10710 |
| 12/22/2023 | 12/26/2023 | 12/28/2023 | $0.13500 | $0.00000 | $0.00000 | $0.00000 | $0.13500 |
| 12/23/2022 | 12/27/2022 | 12/29/2022 | $0.06526 | $0.00000 | $0.00000 | $0.00000 | $0.06526 |
Thought Leadership
Christopher Gannatti, CFA
The First Mass-Market Robots May Not Walk. They May Fly.
Cheap drones are reshaping warfare and industry alike, with Ukraine targeting production of more than 7 million units in 2026 and governments increasingly treating drones as strategic infrastructure. Christopher Gannatti makes the case that drones—not humanoid robots—could become the first truly mass-market form of physical AI, with implications spanning defense, logistics, agriculture and automation.
- Megatrends
Christopher Gannatti, CFA
Glass and Light: The Infrastructure Layer of the Quantum Market Is Missing
Nvidia’s multibillion-dollar investments in photonics aren't just fueling AI, they may be quietly building the backbone of future quantum computing. Christopher Gannatti makes the case that companies like Lumentum, Corning, and Cisco could benefit from a long-term quantum infrastructure buildout, even as AI remains the primary driver today.
- Megatrends
- Quantum computing
Christopher Gannatti, CFA
Can America Build Things? Tracking U.S. Progress in Robotics and Drone Manufacturing
The race for Physical AI will not be won by software alone. It will depend on who can build the robots, drones, and components powering the next industrial era. Christopher Gannatti makes the case that while the U.S. still trails China in manufacturing scale, accelerating investment, policy support, and vertical integration are beginning to reshape the competitive landscape.
- Megatrends
- Artificial Intelligence
- Equities
Christopher Gannatti, CFA
Mind the Bottlenecks: How AI Infrastructure Exposure Separates Today's Technology Strategies
AI's next bottleneck isn't processing power. It's the memory and networking infrastructure needed to move and process data at scale. Christopher Gannatti explains why investors should distinguish between broad AI exposure and targeted exposure to the hardware constraints increasingly shaping AI performance and investment spending.
- Artificial Intelligence
- Megatrends
Documents
Product
Collateral
Reports and Regulatory
Other Links and Documents
Important Risk Information
This information must be preceded or accompanied by a prospectus, click here to view or download prospectus. We advise you to consider the fund's objectives, risks, charges and expenses carefully before investing. The prospectus contains this and other important information about the fund. Please read the prospectus carefully before you invest.
There are risks associated with investing, including possible loss of principal. The Fund invests in BioRevolution companies, which are companies significantly transformed by advancements in genetics and biotechnology. BioRevolution companies face intense competition and potentially rapid product obsolescence. These companies may be adversely affected by the loss or impairment of intellectual property rights and other proprietary information or changes in government regulations or policies. Additionally, BioRevolution companies may be subject to risks associated with genetic analysis. The Fund invests in the securities included in, or representative of, its Index regardless of their investment merit and the Fund does not attempt to outperform its Index. The composition of the Index is governed by an Index Committee and the Index may not perform as intended. Please read the Fund’s prospectus for specific details regarding the Fund’s risk profile.
- Fund Distribution Yield - Fund Distribution Yield is calculated by annualizing the most recent Fund distribution and dividing by the current Fund NAV. The yield represents a single distribution from the Fund and does not represent the total returns of the Fund.
- SEC 30-day Yield – The yield figure reflects the dividends and interest earned during the period, after the deduction of the fund's expenses. This is also referred to as the "standardized yield"
WisdomTree Funds are distributed by Foreside Fund Services, LLC in the U.S. only.
Neither WisdomTree, Inc., nor its affiliates, nor Foreside Fund Services, LLC, or its affiliates provide tax advice. All references to tax matters or information provided on this site are for illustrative purposes only and should not be considered tax advice and cannot be used for the purpose of avoiding tax penalties. Investors seeking tax advice should consult an independent tax advisor.